STACY ANDREWS: Open Payments
NPI 1952985624 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 27 payments from 10 companies in 2025. Trend: 2023 $821 · 2024 $929 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $203 |
| Regeneron Healthcare Solutions, Inc. | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $103 |
| Medtronic, Inc. | 2 | $101 |
| E.R. Squibb & Sons, L.L.C. | 4 | $98 |
| Edwards Lifesciences Corporation | 1 | $61 |
| Boston Scientific Corporation | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Novo Nordisk Inc | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: ELIQUIS, EVKEEZA, JARDIANCE, LINQ II, CAMZYOS, SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, LEQVIO.
Industry payments across TX — which companies pay providers there.
